AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31763984
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of allogeneic cardiosphere-derived cells (CDCs) - four escalating doses (37.5-75 million cells)
Trial: 11678974
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (metformin + glimepiride)
Trial: 23980620
Drug: Standard-dose stavudine
RxNorm normalized name: Stavudine
DrugBank: Stavudine (DB00649)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose stavudine (30-40 mg)
Trial: 23980620
Drug: Low-dose stavudine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose stavudine (20-30 mg)
Trial: 16480404
Drug: Ranitidine 75
RxNorm normalized name: ranitidine 75 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 75 mg at bedtime
Trial: 3816530
Drug: Positive incentive
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive incentive procedure (dose increase for drug-free urines)
Trial: 3816530
Drug: Negative incentive
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative incentive procedure (dose decrease for drug-positive urines)
Trial: 3816530
Drug: Dose decrease
RxNorm normalized name: Titanium Dioxide 7.2 g in 100 mL / Zinc Oxide 4 g in 100 mL TOPICAL LIQUID [Decree Daily Shield Broad Spectrum SPF 30 Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose decrease condition
Trial: 7784339
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release acetaminophen (paracetamol) tablet A
Trial: 9043840
Drug: Antianginal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antianginal therapy (nitrates and calcium antagonists)
Trial: 18486739
Drug: Ustekinumab 90
RxNorm normalized name: ustekinumab 90 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab 90 mg
Trial: 11903465
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) administered at 18 mg/kg as an intravenous intraoperative load, followed by daily doses to maintain serum PHT concentrations within the 10-20 aeg/ml range for 7 days.
Trial: 11903465
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no PHT administered).
Trial: 9532988
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg controlled‐release aspirin
Trial: 21209397
Drug: Sulindac 150
RxNorm normalized name: sulindac 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac 150 mg bid
Trial: 19335924
Drug: Daidzein (DAI)
DrugBank: Daidzein (DB13182)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daidzein (DAI) and daidzein-7-O-beta-D-glucoside (DG) (1 mg DAI aglycone equivalents/kg body weight)
Trial: 17768180
Drug: 10 billion
RxNorm normalized name: CVS Probiotic 10 Billion Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 billion heat-killed L. acidophilus LB plus 160 mg of spent culture medium
Trial: 11837149
Drug: Propofol groups
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol groups (both doses)
Trial: 19608566
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin during IVF and first trimester of pregnancy
Trial: 3136831
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg recombinant tissue plasminogen activator
Trial: 3136831
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg recombinant tissue plasminogen activator
Trial: 3136831
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg recombinant tissue plasminogen activator
Trial: 26234442
Drug: Insulin detemir
RxNorm normalized name: Insulin Detemir
DrugBank: Insulin detemir (DB01307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin detemir (Levemir) and biphasic insulin (NovoMix70)
Trial: 15808033
Drug: Cessation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cessation of quinine treatment
Trial: 30924071
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral medication
Trial: 27555198
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg morphine + 75 μg clonidine
Trial: 22556178
Drug: Alcohol and
RxNorm normalized name: Polyvinyl alcohol and povidone only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol and 1 mg citric acid
Trial: 12975186
Drug: Cold gel
RxNorm normalized name: Deep Freeze Cold Gel
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold gel (Ice Power)
Trial: 1640004
Drug: Sertraline 100
RxNorm normalized name: sertraline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 100 mg administered twice on day 8
Trial: 26232942
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of cardiosphere-derived cells (CDCs)
Trial: 8916626
Drug: therapy
RxNorm normalized name: Ice Therapy
DrugBank: Levomenthol (DB00825)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: therapy
Trial: 17940609
Drug: AMA1-C1 vaccine
RxNorm normalized name: C1-INH
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-C1 vaccine (5, 20, and 80 microg doses)
Trial: 17940609
Drug: AMA1-C1 vaccine
RxNorm normalized name: C1-INH
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-C1 vaccine (80 microg dose)
Trial: 17940609
Drug: AMA1-C1 vaccine
RxNorm normalized name: C1-INH
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-C1 vaccine
Trial: 17940609
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (Hepatitis B vaccine - Recombivax)
Trial: 8922515
Drug: Chemically cured
RxNorm normalized name: Cocci-Cure C for Calves
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemically cured adhesive (Lee Insta‐bond, Lee Pharmaceuticals, EI Monte, Calif.)
Trial: 25001954
Drug: Cortisol (CRT)
RxNorm normalized name: Corticool
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cortisol (CRT) 40 mg
Trial: 23085738
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg loading dose (LD) followed by 7.5 mg maintenance dose (MD) for 10 days
Trial: 23085738
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg loading dose (LD) followed by 5 mg maintenance dose (MD) for 10 days
Trial: 28501668
Drug: fluoroquinolone monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluoroquinolone monotherapy
Trial: 8147243
Drug: No therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapy (group 2)
Trial: 3539613
Drug: Isosorbide-5-mononitrate (5-ISMN)
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (5-ISMN) 60 mg in a controlled release formulation (Durules) given once daily
Trial: 31248918
Drug: Oral gabapentin
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral gabapentin (300‐2700 mg)
Trial: 19834330
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (Control group)
Trial: 8646821
Drug: Intravenous ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ethanol (0.3 gm/kg)
Trial: 15292333
Drug: Low-dose GH
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose GH (1.7 microg/kg.d)
Trial: 19663688
Drug: Liquid diclofenac
RxNorm normalized name: diclofenac Oral Liquid Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid diclofenac formulation (1 mL, 25 mg)
Trial: 16604967
Drug: 50 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 ml of saline solution with 100 ml of contrast material (300 mgI/ml)
Trial: 19639462
Drug: Ferrous sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulfate (520 mg once a day)
Trial: 335789
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) 400 mg per day
Trial: 18221460
Drug: Nebulized budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized budesonide (0.25 mg twice daily for 6 weeks, then half dose for another 6 weeks)
Trial: 1348805
Drug: Injection treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection treatment (1‐2 ml of 1 in 10,000 adrenaline injected at four to six sites around the ulcer)
Trial: 8227938
Drug: Spray to
RxNorm normalized name: DERMUSPRAY TOP AEROSOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray to eyes that were closed
Trial: 21973111
Drug: Enhanced treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced treatment group
Trial: 15370633
Drug: Fluoridated milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoridated milk (250 mL, 5 ppm F)
Trial: 19644125
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for complex targets
Trial: 12623986
Drug: Cyclosporine therapy
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine therapy
Trial: 11970744
Drug: Exemestane (EXE)
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exemestane (EXE) 25 mg once daily (n=366)
Trial: 7723663
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment for 2 years (Group 1)
Trial: 30262574
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment in addition to standard of care)
Trial: 10821460
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin replacement therapy
Trial: 10978944
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg loperamide
Trial: 1447035
Drug: Adjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapy (chemotherapy (5‐FU/FAM) alone, radiation therapy alone, or chemotherapy+radiation therapy)
Trial: 17608947
Drug: Emergency surgery
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emergency surgery (current standard treatment)
Trial: 1797522
Drug: Motivation programme
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivation programme (individual and group basis with client-centred and cognitive-behavioural therapy approaches)
Trial: 6420832
Drug: Chlorimipramine (CI)
RxNorm normalized name: Chlorimipramine
DrugBank: Clomipramine (DB01242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorimipramine (CI) 25 mg
Trial: 22759333
Drug: Lansoprazole with
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lansoprazole with amoxicillin and clarithromycin (LAC)
Trial: 19171708
Drug: IFN-alpha-2a 9
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN-alpha-2a 9 million U three times weekly
Trial: 8787880
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g over 24 h continuous infusion (CI)
Trial: 11568071
Drug: Endovascular graft
RxNorm normalized name: polyvinyl alcohol graft polyethylene glycol copolymer (3:1; 45000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular graft (EVG) treatment
Trial: 17159824
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen therapy (0.05 mg daily)
Trial: 15897165
Drug: Calcipotriol solution
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol solution 0.005%
Trial: 15055895
Drug: 14-G cannula
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 14-G cannula with local anaesthesia
Trial: 3396547
Drug: Suxamethonium administration
RxNorm normalized name: suxamethonium
DrugBank: Succinylcholine (DB00202)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suxamethonium administration
Trial: 16267659
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR (75 mg daily)
Trial: 2372037
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives containing 30 to 50 micrograms of ethinyl estradiol
Trial: 9401083
Drug: First CR
RxNorm normalized name: Acetaminophen/Pamabrom 325 MG-25 MG Oral Tablet [MEDI-FIRST CRAMP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First CR duration >= 12 months and WBC count at relapse < 20 x 10(9)/l
Trial: 7525055
Drug: Carboplatin (CBDCA)
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin (CBDCA) at a maximum tolerated dose of 1000 mg/m2, administered at 14-day intervals, supported by peripheral blood progenitors and filgrastim.
Trial: 7525055
Drug: Carboplatin (CBDCA)
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin (CBDCA) at various dose levels: Level I (500 mg/m2), Level II (800 mg/m2), Level III (1200 mg/m2), Level IIIa (1000 mg/m2), and Level IV (1000 mg/m2) plus cyclophosphamide (CPA) at 1500 mg/m2.
Trial: 7525055
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBDCA (1000 mg/m2) plus CPA (1500 mg/m2) in Level IV.
Trial: 12686335
Drug: Fenofibrate 200
RxNorm normalized name: fenofibrate 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 200 mg/day
Trial: 12685617
Drug: Chronic nitrate
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic nitrate treatment for 6 months after MI
Trial: 23569308
Drug: Docetaxel plus
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel plus zibotentan 10 mg/d
Trial: 11396760
Drug: Sclerotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sclerotherapy with a 3% ethanolamine oleate solution (group 1, 18 patients)
Trial: 16154241
Drug: Subcutaneous measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous measles vaccine (10(4.28) CCID50/0.5 mL)
Trial: 24267258
Drug: High potency
RxNorm normalized name: High Potency B+C
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High potency statins and combined therapy
Trial: 19454639
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (CBT plus zolpidem) followed by CBT alone
Trial: 12217810
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose anti-thymocyte globulin (ATG) early treatment group
Trial: 668784
Drug: Oral chlordiazepoxide
RxNorm normalized name: Chlordiazepoxide
DrugBank: Chlordiazepoxide (DB00475)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral chlordiazepoxide hydrochloride (100 mg)
Trial: 10088935
Drug: Inhaled carbachol
RxNorm normalized name: Carbachol
DrugBank: Carbamoylcholine (DB00411)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled carbachol
Trial: 24192015
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (300 mg/day)
Trial: 10672218
Drug: Continuous retraction
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous retraction force averaging 18 g
Trial: 10672218
Drug: Continuous retraction
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous retraction force averaging 60 g
Trial: 29850244
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg/day
Trial: 6850464
Drug: BCG administered
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG administered orally in nonrandomized studies of patients with malignant melanoma and stage IV breast carcinoma
Trial: 8573687
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg oral dose of terbinafine
Trial: 15234136
Drug: Topical ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ofloxacin applied 1 hour before surgery (control group)
Trial: 31334544
Drug: LD +
RxNorm normalized name: Children's Tylenol Cold + Flu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LD + MCT group (1.2 g l-leucine, 20 μg cholecalciferol, 6 g/d MCTs)
Trial: 23475103
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) pre-treatment for 4 days prior to chemotherapy
Trial: 2850807
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (15-30 g per day)
Trial: 15968231
Drug: Long-term family
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term family therapy (20 sessions over 12 months)
Trial: 26670630
Drug: Half-dose photodynamic
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose photodynamic therapy (PDT)
Trial: 24366433
Drug: Sterile 0.9%
RxNorm normalized name: Sodium Chloride;Vancomycin Hydrochloride;Water, Sterile 0.9%; 1 GM Intravenous Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile 0.9% sodium chloride solution (control)
Trial: 14558957
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine (5-8 times daily)
Trial: 14558957
Drug: Dobell's solution
RxNorm normalized name: Dobell's Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobell's solution (5-8 times daily)
Trial: 10999838
Drug: GH receptor
RxNorm normalized name: Toll-like receptor 9
DrugBank: Toll-like receptor 9 (DB15320)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH receptor antagonist (B2036)
Trial: 8448068
Drug: Isradipine sustained
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine sustained release (I-SRO) 5 mg AM
Trial: 29705650
Drug: Baroreflex activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baroreflex activation therapy (BAT)
Trial: 829223
Drug: Local thiotepa
RxNorm normalized name: Thiotepa
DrugBank: Thiotepa (DB04572)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Local thiotepa chemotherapy after TUR
Trial: 21338187
Drug: Weekly GCSF
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly GCSF therapy before weekly craniospinal radiotherapy